Renaissance Technologies »

Cadrenal Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Cadrenal Therapeutics (CVKD) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Cadrenal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cadrenal Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cadrenal Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2024-03-31 $90k 148k 0.61
2023-12-31 $59k 79k 0.75

More positions owned by Renaissance Technologies

Novo-nordisk A S Adr (NVO)
Palantir Technologies Cl A (PLTR)
Meta Platforms Cl A (META)
Airbnb Com Cl A (ABNB)
Amazon (AMZN)
Vertex Pharmaceuticals Incorporated (VRTX)
Verisign (VRSN)
Uber Technologies (UBER)
NVIDIA Corporation (NVDA)
United Therapeutics Corporation (UTHR)
Chipotle Mexican Grill (CMG)
Franco-Nevada Corporation (FNV)
CBOE Holdings (CBOE)
Exelixis (EXEL)
Crowdstrike Hldgs Cl A (CRWD)

View all positions for Renaissance Technologies

Top funds holding Cadrenal Therapeutics

Armistice Capital
Renaissance Technologies
Citadel Advisors
Geode Capital Management
Virtu Financial
Honkamp Krueger Financial Services
XTX Topco
Biltmore Family Office
Tower Research Capital
Wells Fargo & Company

View all funds holding Cadrenal Therapeutics